Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients

201681 citationsJournal Articlehybrid Open Access

Authors

Jiacong Luo · DaVita Clinical Research (United States)

Donna E. Jensen · DaVita Clinical Research (United States)

Bradley J. Maroni · Akebia Therapeutics (United States)

Steven M. Brunelli · DaVita Clinical Research (United States)

Abstract

When using a contemporary definition at one point in time, ESA hyporesponsiveness was potently and persistently associated with greater mortality, greater iron and ESA use, and lower hemoglobin levels compared to non-ESA hyporesponsiveness.

Topics & Keywords

Erythropoietin and Anemia Treatment Hemoglobinopathies and Related Disorders Dialysis and Renal Disease Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Kidney Diseases

Volume 68, Issue 5, pp. 763-771

DOI: 10.1053/j.ajkd.2016.05.031

Field-Weighted Citation Impact: 3.41